patients. This study reports the first prophylactic LVB in melanoma patients undergoing complete LND for gross metastatic disease.
METHODS:
We present a case series of 15 patients with malignant melanoma who had axillary or ilioinguinal LND for bulky regional involvement and who underwent prophylactic LVB. Details of the surgical procedure, common pitfalls, and indications are discussed.
Five milliliters of indocyanine green (ICG) dye is injected into the hand or foot web spaces. Meticulous complete LND is then started using loupe magnification, minimal cautery dissection, and sharp lymphatic and venous transection. During lymphadenectomy, the lymphatics are assessed using ICG lymphangiography and a fluorescent surgical microscope. Using the multispectrum platform with its rainbow color on-lay software, smaller lymphatic vessels are classified based on their signal intensity, with red indicating the highest intensity and blue the lowest. Those lymphatics that need to be transected and are red on the rainbow color on-lay scale are selected for anastomosis.
RESULTS:
During this study period, 15 patients underwent lymphatic preservation surgery. Multiple subdermal ICG dye injections allowed for visualization of 1-3 transected lymphatics after LND. An average of 1.8 LVBs (range, 1-2) was performed per patient. All the anastomosis were patent as shown by ICG lymphangiography. End-to-end anastomosis was employed in 4 patients, and intussusception anastomosis was performed in 11 patients. LVB operative time varied from 40 to 150 minutes. Drain period ranged from 6 to 18 days.
CONCLUSIONS:
Performing LVB in prophylactic setting with gross metastatic disease in melanoma patients distinguishes our study from others. In our study, using ICG angiography, we identified lymphatic vessels under up to 42× magnification, including those with high flow based on a gradient scale via rainbow color on-lay software system. Traditionally, isosulfan and methylene blue are used for lymphatic visualization. However, they have a risk of severe hypersensitivity reactions, isosulfan blue might interfere with oxygen saturation, and their use is associated with increased incidence of tissue necrosis. Using ICG eliminates these risks. In 2017, Multicenter Selective Lymphadenectomy Trial II showed no survival difference in patients with intermediate-thickness, node-positive melanoma who underwent immediate CLND. Thus, most patients undergoing lymphadenectomy currently have gross, many times bulky metastatic disease. Despite more extirpative surgery as compared to CLND for positive sentinel lymph node biopsy, we were still able to easily identify lymphatics and appropriate recipient veins in all our patients. Expensive and time-consuming radioactive tracer studies were not needed. This technique is reproducible as we have successfully completed this procedure in all 15 consecutive cases. Restoration of lymphatic flow following axillary or ilioinguinal LND in melanoma patients represents a new approach that may decrease the burden of iatrogenic extremity lymphedema.
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PURPOSE: Management of pediatric patients with facial paralysis is challenging, and numerous surgical techniques have been described for smile reconstruction. A free gracilis muscle transfer innervated by a cross-face nerve graft (CFNG) from the contralateral facial nerve or by the ipsilateral motor nerve to masseter (MNTM) is recognized as the gold standard for smile reconstruction owing to its reliable outcomes. Despite the ubiquity of this technique in the pediatric population, there are limited data regarding the rate of secondary surgery to improve the cosmesis, symmetry, or function of the reconstruction. The purpose of this study was to assess the occurrence and type of secondary surgical procedures following pediatric facial reanimation using gracilis muscle transplantation.
METHODS:
Following ethics board approval, a retrospective cohort study was performed and included children who underwent facial reanimation using free gracilis muscle transfer at our pediatric hospital between 1985 and 2014. Medical charts were reviewed to assess secondary surgical procedures performed at least 1 year following the initial reanimation surgery. Procedures related to early postoperative complications, including hematoma or infection, were excluded. Indications for surgical revision were subdivided into major revisions-which involved a non-or poorly functioning muscle transplant necessitating a new gracilis muscle transplant-and minor revisions, where muscle function was acceptable, but surgery was intended to improve cosmesis and/or symmetry.
RESULTS:
There were 261 cases of facial reanimation utilizing a free gracilis muscle transfer between 1985 and 2019. One hundred seventy-three unilateral (66%) and 88 bilateral (34%) reconstructions were performed. Fourteen patients, 7 PSTM 2019 Abstract Supplement Reconstructive Abstracts male and 7 female, required surgical revision (5.4%). The mean time to revision was 2.5 years following the initial surgery. Among patients requiring revision, 10 had muscle transplants innervated by a CFNG, and 4 by the MNTM. There was no statistically significant difference in the rate of revision between CFNG and MNTM (7.7% versus 4.8%; P = 0.4). Minor revisions to improve cosmesis and symmetry were performed in 12 patients (4.6%). Only 2 patients (0.8%) required major revisions, in which the gracilis muscle from the primary surgery was removed and replaced with a new free functioning gracilis muscle. There was no significant difference in revision rate for patients undergoing unilateral versus bilateral procedures (6.8% versus 3.5%; P = 0.4).
CONCLUSIONS:
Our study supports the use of gracilis muscle transplantation as a reliable technique for smile reconstruction in pediatric facial palsy, with low rates of secondary revision. Secondary surgery is most often performed to improve cosmesis and/or symmetry, and major revisions requiring microvascular transplantation of new muscle transfer are rare.
